Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours
نویسندگان
چکیده
منابع مشابه
Prospects for the treatment of endocrine-responsive tumours.
Much has been achieved over the last 30 years to improve the treatment of hormone-dependent cancer of the breast, ovary and prostate. The development of the antioestrogen tamoxifen (Nolvadex) spear-headed a range of drugs that counter the growth-promoting action of the female and male sex steroid hormones. An important additional benefit of endocrine therapies has been their low toxicity compar...
متن کاملEvolutionary emergence of responsive and unresponsive personalities.
In many animal species, individuals differ consistently in suites of correlated behaviors, comparable with human personalities. Increasing evidence suggests that one of the fundamental factors structuring personality differences is the responsiveness of individuals to environmental stimuli. Whereas some individuals tend to be highly responsive to such stimuli, others are unresponsive and show r...
متن کاملThe epidemiology of endocrine tumours.
The epidemiological study of disease aims to increase our understanding of the aetiology, patterns of occurrence and natural history of clinical conditions by reference to populations and defined sub-populations. One of the potential gains from such an approach is the possibility of drawing inferences regarding the contributions of genetic and specific environmental factors in causation. On a m...
متن کاملHormone Production in Endocrine Tumours
HORMONE PRODUCTION IN ENDOCRINE TUMOURS. Ciba Foundation Colloquia on Endocrinology, Vol. 12. G.E.W. Wolstenholme and Maeve O'Connor, Eds. Boston, Little, Brown and Company, 1958. 351 pp. $9.00. This volume is the twelfth in the series of Ciba Foundation Colloquia on Endocrinology, and included in this book is an index to all twelve volumes. According to the preface these published proceedings ...
متن کاملImproved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease
Results from two randomised global trials (SOFT & TEXT) designed to newly define the most effective components of adjuvant endocrine therapy for premenopausal women with endocrine responsive disease, showed that for some, those with high risk of relapse, the use of the aromatase inhibitor exemestane together with ovarian function suppression with GnRH analogue (triptorelin) yielded the most fav...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Endocrine-Related Cancer
سال: 2005
ISSN: 1351-0088,1479-6821
DOI: 10.1677/erc.1.00775a